PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,338,000 | -27.8% | 5,819,729 | +14.1% | 0.00% | -33.3% |
| Q3 2016 | $17,088,000 | +5.2% | 5,101,022 | -1.4% | 0.00% | 0.0% |
| Q2 2016 | $16,243,000 | -0.9% | 5,173,024 | +5.1% | 0.00% | 0.0% |
| Q1 2016 | $16,393,000 | -1.1% | 4,922,887 | +5.1% | 0.00% | 0.0% |
| Q4 2015 | $16,582,000 | -27.9% | 4,684,301 | +2.4% | 0.00% | -25.0% |
| Q3 2015 | $23,012,000 | -22.5% | 4,574,964 | -0.9% | 0.00% | -20.0% |
| Q2 2015 | $29,678,000 | -9.5% | 4,615,542 | -1.0% | 0.01% | 0.0% |
| Q1 2015 | $32,793,000 | -6.8% | 4,661,426 | +2.2% | 0.01% | -16.7% |
| Q4 2014 | $35,168,000 | +3.1% | 4,561,317 | -0.1% | 0.01% | 0.0% |
| Q3 2014 | $34,099,000 | -23.6% | 4,564,824 | -1.0% | 0.01% | -14.3% |
| Q2 2014 | $44,646,000 | +15.5% | 4,612,183 | -0.9% | 0.01% | 0.0% |
| Q1 2014 | $38,667,000 | +4.5% | 4,653,109 | +6.1% | 0.01% | 0.0% |
| Q4 2013 | $37,001,000 | +6.3% | 4,384,036 | +0.3% | 0.01% | 0.0% |
| Q3 2013 | $34,820,000 | +1.2% | 4,368,821 | -2.0% | 0.01% | 0.0% |
| Q2 2013 | $34,399,000 | – | 4,455,860 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |